Transcranial magnetic therapeutic instrument for computer diseases

Abstract

The invention provides a transcranial magnetic therapeutic instrument for computer diseases, comprising a field effect cap which can be worn on head, field effect cap internally being distributed with electrodes and at least one electromagnet; the instrument further comprises an electroencephalographic simulative generator, and the electroencephalographic simulative generator is respectively connected with the electromagnet and the electrodes via conducting wires. In the invention, nerve cell nucleus of intracephalic basal ganglia part can be self-excited by a stereoscopic superposition alternating magnetic field transcranially magnetically formed at intracephalic deep part and a weak induced current formed at a specific part of intracephalic deep part; and the transcranial magnetic effect is strengthened when the nerve cell nucleus transcranially pass through basal ganglia part. The invention is not an interventional therapy but can achieve the functions of stimulating and recovering neurotransmitters of nerve cell nucleus of intracephalic basal ganglia part such as autocrine dopamine, and is applied to encephalopathic therapy such as Parkinson, encephalatrophy, epileptics and gork; the effects exceed that of a brain pacemaker, thereby overcoming the disadvantages of pharmacotherapy and surgical therapy; and the therapeutic instrument can be used in hospital, and is more applied to treatment of patients at home.

Description

(1) Technical field [0001] The invention relates to a medical device, in particular to a therapeutic device for preventing and treating encephalopathy such as Parkinson's, cerebral atrophy, epilepsy and vegetative state. (2) Background technology [0002] Parkinson's disease (Parkinson's disease), also known as "paralysis agitators", is a degenerative disease of the central nervous system. When the function of acetylcholine is reduced, the excitatory effect of acetylcholine is relatively enhanced. The result of the imbalance between the two is "paralysis agitans". The most common age of onset of the disease is 50 to 79 years old. According to foreign statistics, about one person in every 800 people suffers from Parkinson's disease. [0003] The general treatment for Parkinson's disease is to control the disease with the drug dopamine, but the result of long-term medication will cause the function of the part of the brain that can naturally synthesize and secrete dopamine t...

AI Technical Summary

Problems solved by technology

[0016] 1. High cost

The cost of surgery is very expensive. A domestic pacemaker costs more than 100,000 yuan, and an imported pacemaker costs more than 200,000 yuan.

[0017] 2. Patients cannot "leave the service area" after surgery

Doctors must follow up with patients to help solve the problem of discomfort

Images